Public and professional awareness: The Australian Medical Association, collaborating with professional bodies (such as RACGP and RACP), could develop targeted campaigns explaining regulatory approval processes and unregulated product risks, delivered through social media platforms where promotion occurs
Try it out on patchloads.com
This medication is specifically targeted at individuals needing medical assistance to achieve significant long-term weight loss
Tirzepatide , a dual GLP-1/GIP receptor agonist, has been approved by NICE for type 2 diabetes management
Both medications are typically administered as injections and are most effective when combined with a healthy, reduced-calorie diet and increased physical activity
The manufacturer of tirzepatide, Lilly, cautions against taking 2 doses within 3 days of each other